CBMT-07. EVALUATION OF GLYCOLYTIC RESPONSE TO SEVEN CLASSES OF ANTI-GLIOBLASTOMA DRUGS BY NON-INVASIVE MEASUREMENT OF PYRUVATE KINASE M2

INTRODUCTION: Pyruvate kinase M2 (PKM2) catalyzes the final and rate-limiting step in glycolysis, a key step in tumor growth and metabolism. PKM2 is preferentially expressed by glioblastoma (GBM) cells with minimal expression in the healthy brain, making it an important marker of cancer glycolytic r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Beinat, Corinne, Patel, Chirag, Xie, Yuanyang, Gambhir, Sanjiv
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216947/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.126
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak